Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FXFM244 (Minocycline Foam) in Acne Vulgaris
NCT01362010Phase 2Completed
- Sponsor
- Vyne Therapeutics
- Start
- Jan 2012
- Primary completion
- Jun 2013
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zilxi in acne vulgaris, sponsored by Vyne Therapeutics. Started Jan 2012; status: completed.
02
Drugs
zilxi
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01362010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01362010.